Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients

From January 1982 to June 1983 the authors studied the susceptibility to antibiotics of 387 Enterobacteriaceae isolated in our intensive care unit. Thirty percent were resistant to TMP-SMZ. Subgroup analysis with regard to the susceptibility or resistance to TMP-SMZ was performed. The use of TMP-SMZ...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of infectious diseases 1985-05, Vol.151 (5), p.969-969
Main Authors: Riou, B., Richard, C., Rimailho, A., Auzepy, P.
Format: Article
Language:English
Subjects:
Agranulocytosis - complications
Antibiotics
Correspondence
Drug Combinations - adverse effects
Drug Resistance, Microbial
Enterobacteriaceae
Humans
Infections
Neutropenia - complications
Risk
Sulfamethoxazole - adverse effects
Trimethoprim - adverse effects
Trimethoprim, Sulfamethoxazole Drug Combination
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 969
container_issue 5
container_start_page 969
container_title The Journal of infectious diseases
container_volume 151
creator Riou, B.
Richard, C.
Rimailho, A.
Auzepy, P.
description From January 1982 to June 1983 the authors studied the susceptibility to antibiotics of 387 Enterobacteriaceae isolated in our intensive care unit. Thirty percent were resistant to TMP-SMZ. Subgroup analysis with regard to the susceptibility or resistance to TMP-SMZ was performed. The use of TMP-SMZ prophylaxis in neutropenic patients rests on the following two assumptions: TMP-SMZ might reduce the risk of infection and also the rate of infectious morbidity and mortality without allowing infection due to multiresistant strains. Probable increased resistance of Enterobacteriaceae to TMP-SMZ in the future will greatly reduce the benefits of such prophylaxis.
doi_str_mv 10.1093/infdis/151.5.969
format article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_14150285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30135977</jstor_id><sourcerecordid>30135977</sourcerecordid><originalsourceid>FETCH-LOGICAL-c338t-d3340ff53d4611a065c22a5dc5bb6c0e64f246ba720c0d011c5cac0c68b121473</originalsourceid><addsrcrecordid>eNpFkEFP4zAQhS20CArLfS9IOe0t7Ywd28kR0EKREBS2CLQXy3EcYUjjbuxIhV9PSqtyGs28N08zHyG_EMYIBZu4tq5cmCDHMR8XotgjI-RMpkIg-0FGAJSmmBfFITkK4RUAMibkATlguaQFihGZz3y0bXS6SR5ceAuJr5N55xY2vvjlUNO_fVPrr3alP3xjk1nnly_vjV65kLg2ubV9HCa2dSaZ6eiGsPCT7Ne6CfZkW4_J4-Wf-cU0vbm7ur44u0kNY3lMK8YyqGvOqkwgahDcUKp5ZXhZCgNWZDXNRKklBQMVIBputAEj8hIpZpIdk9-b3GXn__c2RLVwwdim0a31fVCYIQea88EIG6PpfAidrdX6N929KwS1Bqk2INUAUnE1gBxWTrfZfbmw1W5hS-5bfw3Rd98yIOOFXN-WbnQXol3tdN29KSGZ5Gr6_E-J86fZVOb36pl9Aj4tilk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14150285</pqid></control><display><type>article</type><title>Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Riou, B. ; Richard, C. ; Rimailho, A. ; Auzepy, P.</creator><creatorcontrib>Riou, B. ; Richard, C. ; Rimailho, A. ; Auzepy, P.</creatorcontrib><description>From January 1982 to June 1983 the authors studied the susceptibility to antibiotics of 387 Enterobacteriaceae isolated in our intensive care unit. Thirty percent were resistant to TMP-SMZ. Subgroup analysis with regard to the susceptibility or resistance to TMP-SMZ was performed. The use of TMP-SMZ prophylaxis in neutropenic patients rests on the following two assumptions: TMP-SMZ might reduce the risk of infection and also the rate of infectious morbidity and mortality without allowing infection due to multiresistant strains. Probable increased resistance of Enterobacteriaceae to TMP-SMZ in the future will greatly reduce the benefits of such prophylaxis.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/151.5.969</identifier><identifier>PMID: 3872916</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Agranulocytosis - complications ; Antibiotics ; Correspondence ; Drug Combinations - adverse effects ; Drug Resistance, Microbial ; Enterobacteriaceae ; Humans ; Infections ; Neutropenia - complications ; Risk ; Sulfamethoxazole - adverse effects ; Trimethoprim - adverse effects ; Trimethoprim, Sulfamethoxazole Drug Combination</subject><ispartof>The Journal of infectious diseases, 1985-05, Vol.151 (5), p.969-969</ispartof><rights>Copyright 1985 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3872916$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riou, B.</creatorcontrib><creatorcontrib>Richard, C.</creatorcontrib><creatorcontrib>Rimailho, A.</creatorcontrib><creatorcontrib>Auzepy, P.</creatorcontrib><title>Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>From January 1982 to June 1983 the authors studied the susceptibility to antibiotics of 387 Enterobacteriaceae isolated in our intensive care unit. Thirty percent were resistant to TMP-SMZ. Subgroup analysis with regard to the susceptibility or resistance to TMP-SMZ was performed. The use of TMP-SMZ prophylaxis in neutropenic patients rests on the following two assumptions: TMP-SMZ might reduce the risk of infection and also the rate of infectious morbidity and mortality without allowing infection due to multiresistant strains. Probable increased resistance of Enterobacteriaceae to TMP-SMZ in the future will greatly reduce the benefits of such prophylaxis.</description><subject>Agranulocytosis - complications</subject><subject>Antibiotics</subject><subject>Correspondence</subject><subject>Drug Combinations - adverse effects</subject><subject>Drug Resistance, Microbial</subject><subject>Enterobacteriaceae</subject><subject>Humans</subject><subject>Infections</subject><subject>Neutropenia - complications</subject><subject>Risk</subject><subject>Sulfamethoxazole - adverse effects</subject><subject>Trimethoprim - adverse effects</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1985</creationdate><recordtype>article</recordtype><recordid>eNpFkEFP4zAQhS20CArLfS9IOe0t7Ywd28kR0EKREBS2CLQXy3EcYUjjbuxIhV9PSqtyGs28N08zHyG_EMYIBZu4tq5cmCDHMR8XotgjI-RMpkIg-0FGAJSmmBfFITkK4RUAMibkATlguaQFihGZz3y0bXS6SR5ceAuJr5N55xY2vvjlUNO_fVPrr3alP3xjk1nnly_vjV65kLg2ubV9HCa2dSaZ6eiGsPCT7Ne6CfZkW4_J4-Wf-cU0vbm7ur44u0kNY3lMK8YyqGvOqkwgahDcUKp5ZXhZCgNWZDXNRKklBQMVIBputAEj8hIpZpIdk9-b3GXn__c2RLVwwdim0a31fVCYIQea88EIG6PpfAidrdX6N929KwS1Bqk2INUAUnE1gBxWTrfZfbmw1W5hS-5bfw3Rd98yIOOFXN-WbnQXol3tdN29KSGZ5Gr6_E-J86fZVOb36pl9Aj4tilk</recordid><startdate>198505</startdate><enddate>198505</enddate><creator>Riou, B.</creator><creator>Richard, C.</creator><creator>Rimailho, A.</creator><creator>Auzepy, P.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>198505</creationdate><title>Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients</title><author>Riou, B. ; Richard, C. ; Rimailho, A. ; Auzepy, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c338t-d3340ff53d4611a065c22a5dc5bb6c0e64f246ba720c0d011c5cac0c68b121473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1985</creationdate><topic>Agranulocytosis - complications</topic><topic>Antibiotics</topic><topic>Correspondence</topic><topic>Drug Combinations - adverse effects</topic><topic>Drug Resistance, Microbial</topic><topic>Enterobacteriaceae</topic><topic>Humans</topic><topic>Infections</topic><topic>Neutropenia - complications</topic><topic>Risk</topic><topic>Sulfamethoxazole - adverse effects</topic><topic>Trimethoprim - adverse effects</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riou, B.</creatorcontrib><creatorcontrib>Richard, C.</creatorcontrib><creatorcontrib>Rimailho, A.</creatorcontrib><creatorcontrib>Auzepy, P.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riou, B.</au><au>Richard, C.</au><au>Rimailho, A.</au><au>Auzepy, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1985-05</date><risdate>1985</risdate><volume>151</volume><issue>5</issue><spage>969</spage><epage>969</epage><pages>969-969</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>From January 1982 to June 1983 the authors studied the susceptibility to antibiotics of 387 Enterobacteriaceae isolated in our intensive care unit. Thirty percent were resistant to TMP-SMZ. Subgroup analysis with regard to the susceptibility or resistance to TMP-SMZ was performed. The use of TMP-SMZ prophylaxis in neutropenic patients rests on the following two assumptions: TMP-SMZ might reduce the risk of infection and also the rate of infectious morbidity and mortality without allowing infection due to multiresistant strains. Probable increased resistance of Enterobacteriaceae to TMP-SMZ in the future will greatly reduce the benefits of such prophylaxis.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>3872916</pmid><doi>10.1093/infdis/151.5.969</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-1899
ispartof The Journal of infectious diseases, 1985-05, Vol.151 (5), p.969-969
issn 0022-1899
1537-6613
language eng
recordid cdi_proquest_miscellaneous_14150285
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Agranulocytosis - complications
Antibiotics
Correspondence
Drug Combinations - adverse effects
Drug Resistance, Microbial
Enterobacteriaceae
Humans
Infections
Neutropenia - complications
Risk
Sulfamethoxazole - adverse effects
Trimethoprim - adverse effects
Trimethoprim, Sulfamethoxazole Drug Combination
title Potential Risks of Trimethoprim-Sulfamethoxazole Prophylaxis in Neutropenic Patients
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-03T12%3A02%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Potential%20Risks%20of%20Trimethoprim-Sulfamethoxazole%20Prophylaxis%20in%20Neutropenic%20Patients&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Riou,%20B.&rft.date=1985-05&rft.volume=151&rft.issue=5&rft.spage=969&rft.epage=969&rft.pages=969-969&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/151.5.969&rft_dat=%3Cjstor_proqu%3E30135977%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c338t-d3340ff53d4611a065c22a5dc5bb6c0e64f246ba720c0d011c5cac0c68b121473%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=14150285&rft_id=info:pmid/3872916&rft_jstor_id=30135977&rfr_iscdi=true